Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | S1PR4 | O95977 | 17/20 | 0.47 |
| ▸ | S1PR2 | O95136 | 6/20 | 0.47 |
| ▸ | S1PR3 | Q99500 | 3/20 | 0.47 |
| ▸ | S1PR5 | Q9H228 | 3/20 | 0.47 |
| ▸ | S1PR1 | P21453 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27327252 | 0.90 | POLB (0.49) | S1PR4S1PR2S1PR3S1PR5S1PR1 | |
| SCHEMBL27331754 | 0.79 | HSD17B2 (0.46) | S1PR4S1PR2S1PR3S1PR5S1PR1 | |
| SCHEMBL1797516 | 0.78 | ALDH1A1 (0.50) | KDM4EALDH1A1MAPT | |
| SCHEMBL27331820 | 0.78 | HSD17B2 (0.47) | S1PR4S1PR2S1PR3S1PR5S1PR1 | |
| SCHEMBL7125633 | 0.78 | ALDH1A1 (0.62) | KDM4EALDH1A1MAPT | |
| SCHEMBL1015370 | 0.77 | KDM4E (0.60) | KDM4EALDH1A1MAPT | |
| SCHEMBL27331752 | 0.76 | KDM4E (0.51) | S1PR4S1PR2S1PR3S1PR5S1PR1 | |
| SCHEMBL9674267 | 0.76 | ALDH1A1 (0.65) | KDM4EALDH1A1MAPT | |
| SCHEMBL6510154 | 0.73 | KMT2A (0.63) | KDM4EALDH1A1 | |
| SCHEMBL30044907 | 0.73 | KMT2A (0.63) | KDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024103400-A1 | POLYCYCLIC COMPOUND AS GPR75 ACTIVATOR, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND USE THEREOF | 水木未来(北京)科技有限公司 | 2024-05-23 | — | — | WO | disclosed |